Gm70 Inhibitors

The chemical class known as PPP1R36 Inhibitors would consist of compounds that primarily inhibit the protein phosphatase 1 (PP1) complex either directly or by influencing its regulatory subunits, such as PPP1R36. Many of the inhibitors listed are toxins or synthetic compounds that have been observed to bind to and inhibit the phosphatase activity of PP1, thereby affecting downstream signaling pathways and biological processes that PPP1R36 is likely to modulate through its association with PP1.

In the first paragraph, the inhibitors encompass natural toxins like Calyculin A, Tautomycetin, Okadaic Acid, Cantharidin, Microcystin-LR, Endothall, Norcantharidin, Rubratoxin B, and synthetic peptides like I-2 and I-1. These molecules bind to the catalytic subunit of PP1 or alter its conformation, preventing it from interacting with its regulatory subunits, such as PPP1R36, or substrate proteins. This inhibition can alter the substrate specificity, localization, and overall function of the PP1 complex. In the second paragraph, the inhibitors also include compounds like Cylindrospermopsin and Sanguinarine. These inhibitors not only affect the dephosphorylation activity of PP1 but may also alter the dynamic assembly of the PP1 holoenzyme complex, which includes PPP1R36. By modulating the composition and the phosphatase activity of the PP1 complex, these inhibitors can influence various cellular processes where PPP1R36 is implicated, such as cell cycle regulation, muscle contraction, and neuronal signaling